
An abstract from the American Heart Association's Scientific Sessions 2026 reveals the continuous expansion of the GLP-1 medication class.
Across the country and as widely reported in the news, recent medical research has revealed that human stem cells may provide breakthrough cures for many common diseases and injuries.






